Close Menu

Back to Court

The Federal Circuit Court of Appeals this week denied Myriad's motion to declare the case against its BRCA patents moot, reports Patent Docs' Kevin Noonan. When the court originally heard the case, it declared that only one of the named plaintiffs, Harry Ostrer, had standing to bring the case because he said he was ready to use the patented BRCA diagnostic method in his practice if the patent was struck down, Noonan says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.